-
1
التحري عن التغير 1846G>A من المورثة CYP2D6 لدى عينة منتقاة عشوائياً من المجتمع السوري
Published 2024-12-01Subjects: Get full text
Article -
2
Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report
Published 2024-11-01Subjects: Get full text
Article -
3
Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparibResearch in context
Published 2024-11-01Subjects: Get full text
Article -
4
-
5
Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol
Published 2024-12-01Subjects: Get full text
Article -
6
Protective effects of YCHD on the autoimmune hepatitis mice model induced by Ad-CYP2D6 through modulating the Th1/Treg ratio and intestinal flora
Published 2024-11-01Subjects: Get full text
Article -
7
Development and validation of a next-generation sequencing panel for clinical pharmacogenetics
Published 2020-11-01Subjects: Get full text
Article -
8
Genetic polymorphism of CYP1A1 and CYP2D6 in populations of Buryats, Teleuts and Russians of Eastern Siberia
Published 2018-04-01Subjects: Get full text
Article -
9
Afro-Latin American Pharmacogenetics of <i>CYP2D6</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Dominicans: A Study from the RIBEF-CEIBA Consortium
Published 2024-10-01Subjects: “…<i>CYP2D6</i>…”
Get full text
Article